We believe in comprehensive programmes to address these issues and ease the access to healthcare in general.Affordability is one of greatest access barriers in Indonesia. About 600,000 people die because of Hepatitis B, while approximately 350,000-500,000 of Hepatitis C.We continue “Fight Hepatitis: Know It, Test It, and Beat It” campaign to encourage general public to seek for reliable information, high risk populations to get tested and start the referral system, and patients to follow the treatment process.We are partnering with the Ministry of Health, the Indonesian Red Cross, and Indonesian Association for the Study of the Liver (PPHI) to organise Hepatitis Day commemorations and various campaign activities, including public seminars.Sixteen public awareness seminars held in Indonesian Red Cross sites were attended by more than 1,500 people in 2015 and 2016. To find out more information about these medications, and 800 other medications available through patient assistance programs, register for free to search the RxAssist database. The disease can be widely deterred if people at higher risk actively drink 8 glasses of water a day, consume types of food that do not contain too much salt, and have regular kidney function examination.Through the campaign “Healthy Kidney for All”, we attempt to increase public awareness on chronic kidney disease and educate people about renal transplant. Your physician/prescriber does not need to Co-organized with Center for Health Economics and Policy Studies (CHEPS) we also initiated a public discussion “When Economics and Health Meet”,Another key policy discussion where we deeply engaged is the cancer control policy. The Ministry of Health estimates that deaths caused by cancer accounts for 13 percent of all deaths in the country. UHC does not always cover all types of medicine or full cycle of treatment; thus treatment cost becomes a major deterrent for patients in completing treatment. Xubex offers assistance to individuals for generic medications. Access to innovative treatment is a serious issue for many patients in Indonesia. Cefixime is a member of the third generation cephalosporins drug class and is commonly used for Bladder Infection, Bronchitis, Gonococcal Infection - Disseminated, and others.The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.Please note: This is a drug discount program, not an insurance plan. Suboptimal knowledge, inaccurate information, cultural taboo, myths, fear, and poverty often deter people from seeing physicians. Therefore, there is a critical need to ease the access to our innovative treatment.Since 2009, we have been showing commitment to help patients alleviating treatment cost burden by providing patient assistance programme.

Partnering with patient organizations, community and private sectors, we organized series of public education such as public seminars, education materials, and media relations.The campaign launch was attended by around 200 participants who represented partners, healthcare professionals associations, community organisations, as well as patient organisations, showing a mutual commitment to the “Let’s Defeat Cancer Together” campaign.Various education materials were developed, including three animation videos, which has more than 30,000 online viewers and reached more than 100,000 people nationwide. “Check Your Bowel Movement, Detect Colorectal Cancer” campaign is the first ever nationwide campaign in Indonesia targeting colorectal cancer, starting with the very simple step of changing people’s behaviour in the toilets.The International Agency for Research on Cancer estimates that ovarian cancer has the highest mortality rate of all gynaecological cancers. As a developing country with medium per capita income and huge socioeconomic disparity, Indonesia has been struggling to provide quality healthcare that serves everyone throughout the archipelago.

Together with other stakeholders, we engaged in series of dialogues on the topic to encourage policy change. Eligibility requirements vary for each program.There are currently no Patient Assistance Programs that we know about for this drug.The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records.

Around 70% of cancer patients in Indonesia see physicians at the late stage due to low awareness, cultural taboo, fear, as well as inadequate and inaccurate information on cancer and cancer treatment.We launched a national level public education campaign “Let’s Defeat Cancer Together”. As a developing country with medium per capita income and huge socioeconomic disparity, Indonesia has been struggling to provide quality healthcare that serves everyone throughout the archipelago. For more, please visit our COVID-19 response page.

Section 2 is your prescription. Amongst other key initiatives was our partnership with Indonesian Health Economic Association (InaHEA) where we supported policy discussion on healthcare financing during their key congress,  attended by 2,000 participants. Together with the Ministry of Health, we are committed to help raising public awareness on diseases that are our expertise areas.Approximately 240 million people worldwide suffer from chronic liver disease.

Patient Assistance Programme Affordability is one of greatest access barriers in Indonesia. We also believe on the emerging role of patient organization in the policy discussions.

Two animation videos on Hepatitis B and Hepatitis C were developed and promoted, and by the facilitation of the ministry, have been broadcasted on the giant screen in Indonesia’s major cities.Cancer has become a major health issue in Indonesia. Merck Patient Assistance Program PO Box 690 Horsham, PA 19044-9979 Please Note: Incomplete or incorrectly completed applications will be returned. dietary changes and tobacco smoking. Xubex’s Patient Assistance Program is one of the most innovative, best and patient friendly Patient Assistance Programs available.